PMG
DMK

Private Management Group’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Private Management Group’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-150
Closed -$5K – 144
2020
Q4 		$5K Hold
150
– – ﹤0.01% 131
2020
Q3 		$8K Buy
+150
New +$8.89K ﹤0.01% 122

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Private Management Group's DMK Position: Q1 2021 in Review

Private Management Group sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2021, closing a stake of 150 shares — an estimated $5K sold.

Private Management Group first reported a position in DMK in Q3 2020 and held it in 2 quarters. The position peaked at $8K in Q3 2020. 53 funds tracked by Wall St. Rank hold DMK as of Q1 2021.

  • Private Management Group reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2021 after selling out during the quarter.
  • Private Management Group sold 150 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2021, an estimated $5K.
  • Private Management Group first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2020 and held it in 2 quarters.
  • Private Management Group's DMK Pharmaceuticals Corporation Common Stock position peaked at $8K in Q3 2020.
  • 53 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2021.

Based on Private Management Group's 13F filing for Q1 2021, filed 11 May 2021.